| Phosphorylation of eIF2α in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase A Yerlikaya, SR Kimball, BA Stanley Biochemical Journal 412 (3), 579-588, 2008 | 98 | 2008 |
| The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib A Yerlikaya, E Okur, E Ulukaya Tumor Biology 33, 1385-1392, 2012 | 78 | 2012 |
| Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade A Yerlikaya, N Erin International journal of molecular medicine 22 (6), 817-823, 2008 | 59 | 2008 |
| Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line ŞA Düzgün, A Yerlikaya, S Zeren, Z Bayhan, E Okur, İ Boyacı Cytotechnology 69, 711-724, 2017 | 56 | 2017 |
| Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line A Yerlikaya, E Okur, S Şeker, N Erin Molecular medicine reports 3 (2), 333-339, 2010 | 56 | 2010 |
| S-adenosylmethionine decarboxylase degradation by the 26 S proteasome is accelerated by substrate-mediated transamination A Yerlikaya, BA Stanley Journal of Biological Chemistry 279 (13), 12469-12478, 2004 | 49 | 2004 |
| Variations in fatty acids composition of pikeperch (Sander lucioperca) liver with respect to gonad maturation K Uysal, A Yerlikaya, MY Aksoylar, M Yöntem, M Ulupinar Ecology of Freshwater Fish 15 (4), 441-445, 2006 | 42 | 2006 |
| The significance of ubiquitin proteasome pathway in cancer development A Yerlikaya, M Yontem Recent patents on anti-cancer drug discovery 8 (3), 298-309, 2013 | 38 | 2013 |
| A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line A Yerlikaya, E Okur, AT Baykal, C Acılan, İ Boyacı, E Ulukaya Journal of proteomics 113, 315-325, 2015 | 34 | 2015 |
| Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3 B Aras, A Yerlikaya Oncology letters 11 (5), 3179-3184, 2016 | 29 | 2016 |
| Effect of bortezomib in combination with cisplatin and 5‑fluorouracil on 4T1 breast cancer cells A Yerlikaya, S Altıkat, R Irmak, FZ Cavga, SA Kocacan, I Boyaci Molecular medicine reports 8 (1), 277-281, 2013 | 25 | 2013 |
| A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib A Yerlikaya, E Erdoğan, E Okur, Ş Yerlikaya, B Savran Oncology Letters 12 (1), 323-330, 2016 | 21 | 2016 |
| Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro E Ulukaya, M Sarimahmut, B Cevatemre, F Ari, A Yerlikaya, K Dimas Biomedicine & Pharmacotherapy 68 (4), 477-482, 2014 | 20 | 2014 |
| Protein yıkımının önemi A Yerlikaya, H Dokudur Uludağ Üniversitesi Tıp Fakültesi Dergisi 35 (2), 93-99, 2009 | 20 | 2009 |
| Polyamines and S-adenosylmethionine decarboxylase A Yerlikaya Turk. J. Biochem 29, 208-214, 2004 | 19 | 2004 |
| Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructive pulmonary disease in the Turkish population C Ayada, Ü Toru, O Genç, A Yerlikaya, S Şahin, S Turgut, G Turgut Genetics and Molecular Research, 2014 | 17 | 2014 |
| Investigation of the eIF2α phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells A Yerlikaya, H Dokudur Molecular biology 44, 760-768, 2010 | 16 | 2010 |
| Influence of dietary oils on liver and blood lipid peroxidation. S Ergun, M Yontem, A Yerlikaya, A Ozata, K Uysal, H Kurt Saudi medical journal 26 (3), 442-446, 2005 | 16 | 2005 |
| Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer N Erin, N Ogan, A Yerlikaya Breast Cancer Research and Treatment 170, 235-250, 2018 | 15 | 2018 |
| The ubiquitin-proteasome pathway and epigenetic modifications in cancer A Yerlikaya, E Kanbur, BA Stanley, E Tümer Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021 | 13 | 2021 |
Emrah Okur在 dpu.edu.tr 的电子邮件经过验证
Emrah Okur在 dpu.edu.tr 的电子邮件经过验证
Engin UlukayaMedical Faculty of Istinye University, Istanbul, Turkey在 istinye.edu.tr 的电子邮件经过验证